×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: TGR5 Agonist Therapy
therapeutic
1,441 words
KG: TGR5
2026-03-23
kind:therapeutic
section:therapeutics
state:published
Contents
TGR5 Agonist Therapy
💊
Therapeutic Info
Name
TGR5 Agonist Therapy
Summary
Page for TGR5 Agonist Therapy
Key Genes/Proteins
NFE2L2
,
NRF2
,
STAT3
Related Diseases
Motor Dysfunction
,
Parkinson's Disease
,
Alzheimer's disease
Knowledge Graph
Related Hypotheses (30)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Conversion Therapy
Score: 0.44
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
CYP46A1 Overexpression Gene Therapy
Score: 0.63
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
PARP1 Inhibition Therapy
Score: 0.58
TREM2-Mediated Cholesterol Dysregulation in Microglial Senes
Score: 0.57
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli
Score: 0.57
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat
Score: 0.52
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51
Ganglioside Rebalancing Therapy
Score: 0.50
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
Orexin-Microglia Modulation Therapy
Score: 0.49
Microglial Purinergic Reprogramming
Score: 0.48
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Complement C1q Mimetic Decoy Therapy
Score: 0.48
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47
Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention fo
Score: 0.47
Arginine Methylation Enhancement Therapy
Score: 0.46
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Show 25 more
Related Analyses (22)
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Show 17 more
Related Experiments (7)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Acteoside treatment in LPS-induced SALI mouse model
validation · proposed · Score: 0.90
Resveratrol protection against renal I/R injury in diabetic
validation · proposed · Score: 0.90
Nrf2 inhibitor ML385 mechanism validation experiment
exploratory · proposed · Score: 0.85
Acteoside effects on RAW264.7 macrophage cells
exploratory · proposed · Score: 0.85
Resveratrol effects on HK-2 cells under hypoxia/reoxygenatio
exploratory · proposed · Score: 0.85
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.40
Show 2 more
See Also (15)
Neuroprotection Strategies in Neurodegeneration
therapeutic · KG edge: mediates
NRF2 Activator Therapy
idea · KG edge: activates
NRF2 Gene
gene · KG edge: activates
NFE2L2 — Nuclear Factor Erythroid 2-Related Factor 2
gene · KG edge: activates
STAT3 (Redirect)
redirect · KG edge: activates
NeuRon Therapeutics
company · KG edge: expressed_in
LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 5 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 5 hypotheses
LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 4 hypotheses
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
WNK1 Kinase in Neurodegeneration
mechanism · Pages share 3 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 3 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 3 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 3 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
Show 10 more
Knowledge Graph (12 edges)
TGR5
activates
NRF2
TGR5
activates
STAT3
TGR5
expressed_in
neuron
TGR5
activates
NFE2L2
TGR5
associated_with
Alzheimer's disease
TGR5
involved_in
Parkinson's Disease
TGR5
mediates
Neuroprotection
TGR5
regulates
Motor Dysfunction
GPS
activates
TGR5
DCA
activates
TGR5